Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.

Br J Cancer · 2026 · PMC13226680 · PMID 41957139

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

nearly significantp = 0.06so close (0.05 < p ≤ 0.1)

Concerning OS, we observed a strong and nearly significant ( p = 0.06) reduction in hazard ratio (HR = 0.43, CI: 0.18–1.04) for BRAF patients.

also in 3,287 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.